Summit Therapeutics, Inc. (SMMT)
16.49
-0.88
(-5.07%)
USD |
NASDAQ |
Jan 23, 16:00
16.56
+0.07
(+0.42%)
Pre-Market: 20:00
Summit Therapeutics EPS Diluted (Quarterly): -0.3118 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Insmed, Inc. | -1.747 |
| Madrigal Pharmaceuticals, Inc. | -5.079 |
| Viridian Therapeutics, Inc. | -0.423 |
| Vivani Medical, Inc. | -0.1094 |
| Alumis, Inc. | -1.064 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -231.79M |
| Total Expenses (Quarterly) | 231.79M |
| Enterprise Value | 12.04B |
| Earnings Yield | -7.53% |
| Normalized Earnings Yield | -7.531 |